Association of Time to Kidney Transplantation With Graft Failure Among US Patients With End-Stage Renal Disease Due to Lupus Nephritis

被引:36
|
作者
Plantinga, Laura C. [1 ,2 ]
Patzer, Rachel E. [3 ,4 ]
Drenkard, Cristina [4 ]
Kramer, Michael R. [1 ]
Klein, Mitchel [1 ]
Lim, S. Sam [4 ]
McClellan, William M. [1 ]
Pastan, Stephen O. [3 ,4 ]
机构
[1] Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA
[2] Emory Univ, Laney Grad Sch, Atlanta, GA 30322 USA
[3] Emory Healthcare, Emory Transplant Ctr, Atlanta, GA USA
[4] Emory Univ, Sch Med, Atlanta, GA 30322 USA
关键词
HEALTH DISPARITIES; OUTCOMES; RECIPIENTS; MORTALITY; DIALYSIS; ACCESS; GUIDELINES;
D O I
10.1002/acr.22482
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
ObjectiveProviders recommend waiting to transplant patients with end-stage renal disease (ESRD) secondary to lupus nephritis (LN), to allow for quiescence of systemic lupus erythematosus (SLE)-related immune activity. However, these recommendations are not standardized, and we sought to examine whether duration of time to transplant was associated with risk of graft failure in US LN-ESRD patients. MethodsUsing national ESRD surveillance data (United States Renal Data System), we identified 4,743 US patients with LN-ESRD who received a first transplant on or after January 1, 2000 (followup through September 30, 2011). The association of wait time (time from ESRD start to transplant) with graft failure was assessed with Cox proportional hazards models, with splines of the exposure to allow for nonlinearity of the association and with adjustment for potential confounding by demographic, clinical, and transplant factors. ResultsWhite LN-ESRD patients who were transplanted later (versus at <3 months receiving dialysis) were at increased risk of graft failure (3-12 months: adjusted hazard ratio [HR] 1.23, 95% confidence interval [95% CI] 0.93-1.63; 12-24 months: adjusted HR 1.37, 95% CI 0.92-2.06; 24-36 months: adjusted HR 1.34, 95% CI 0.92-1.97; and >36 months: adjusted HR 1.98, 95% CI 1.31-2.99). However, no such association was seen among African American recipients (3-12 months: adjusted HR 1.07, 95% CI 0.79-1.45; 12-24 months: adjusted HR 1.01, 95% CI 0.64-1.60; 24-36 months: adjusted HR 0.78, 95% CI 0.51-1.18; and >36 months: adjusted HR 0.74, 95% CI 0.48-1.13). ConclusionWhile future studies are needed to examine the potential confounding effect of clinically recognized SLE activity on the observed associations, these results suggest that longer wait times to transplant may be associated with equivalent or worse, not better, graft outcomes among LN-ESRD patients.
引用
收藏
页码:571 / 581
页数:11
相关论文
共 50 条
  • [1] Long-term outcomes of end-stage kidney disease for patients with lupus nephritis
    Zhang, Lei
    Lee, Gavin
    Liu, Xusheng
    Pascoe, Elaine M.
    Badve, Sunil V.
    Boudville, Neil C.
    Clayton, Philip A.
    Hawley, Carmel M.
    Kanellis, John
    McDonald, Stephen P.
    Peh, Chen Au
    Polkinghorne, Kevan R.
    Johnson, David W.
    KIDNEY INTERNATIONAL, 2016, 89 (06) : 1337 - 1345
  • [2] End-Stage Renal Disease Due to Lupus Nephritis Among Children in the US, 1995-2006
    Hiraki, Linda T.
    Lu, Bing
    Alexander, Steven R.
    Shaykevich, Tamara
    Alarcon, Graciela S.
    Solomon, Daniel H.
    Winkelmayer, Wolfgang C.
    Costenbader, Karen H.
    ARTHRITIS AND RHEUMATISM, 2011, 63 (07): : 1988 - 1997
  • [3] Trends in the Incidence, Demographics, and Outcomes of End-Stage Renal Disease Due to Lupus Nephritis in the US From 1995 to 2006
    Costenbader, Karen H.
    Desai, Amrita
    Alarcon, Graciela S.
    Hiraki, Linda T.
    Shaykevich, Tamara
    Brookhart, M. Alan
    Massarotti, Elena
    Lu, Bing
    Solomon, Daniel H.
    Winkelmayer, Wolfgang C.
    ARTHRITIS AND RHEUMATISM, 2011, 63 (06): : 1681 - 1688
  • [4] Variation in initial kidney replacement therapy for end-stage renal disease due to lupus nephritis in the United States
    Devlin, Amy
    Waikar, Sushrut
    Solomon, Daniel H.
    Lu, Bing
    Shaykevich, Tamara
    Alarcon, Graciela S.
    Winkelmayer, Wolfgang C.
    Costenbader, Karen H.
    ARTHRITIS CARE & RESEARCH, 2011, 63 (12) : 1642 - 1653
  • [5] Racial and Ethnic Differences in Mortality and Cardiovascular Events Among Patients With End-Stage Renal Disease Due to Lupus Nephritis
    Gomez-Puerta, Jose A.
    Feldman, Candace H.
    Alarcon, Graciela S.
    Guan, Hongshu
    Winkelmayer, Wolfgang C.
    Costenbader, Karen H.
    ARTHRITIS CARE & RESEARCH, 2015, 67 (10) : 1453 - 1462
  • [6] Clinical outcomes of kidney transplants on patients with end-stage renal disease secondary to lupus nephritis, polycystic kidney disease and diabetic nephropathy
    Fredy Nieto-Rios, John
    Maria Serna-Higuita, Lina
    Alexandra Builes-Rodriguez, Sheila
    Cesar Restrepo-Correa, Ricardo
    Aristizabal-Alzate, Arbey
    Ocampo-Kohn, Catalina
    Serna-Campuzano, Angelica
    Cardona-Diaz, Natalia
    Dario Giraldo-Ramirez, Nelson
    Adolfo Zuluaga-Valencia, Gustavo
    COLOMBIA MEDICA, 2016, 47 (01): : 51 - 58
  • [7] Lupus activity in lupus nephritis patients with end-stage renal disease treated with hemodialysis
    Morad, Caroline Samy
    Zaiema, Shams ElDoha Galal
    Hafez, Eman Ahmed
    Mansour, Mohammed Maher Mohammed Mohammed
    Khalil, Amr Elsayed Mohammed Abd-Allah
    Hassan, Shaymaa Gamal Arafa
    EGYPTIAN JOURNAL OF INTERNAL MEDICINE, 2025, 37 (01):
  • [8] Racial/Ethnic Differences in the Association Between Hospitalization and Kidney Transplantation Among Waitlisted End-Stage Renal Disease Patients
    Newman, Kira L.
    Fedewa, Stacey A.
    Jacobson, Melanie H.
    Adams, Andrew B.
    Zhang, Rebecca
    Pastan, Stephen O.
    Patzer, Rachel E.
    TRANSPLANTATION, 2016, 100 (12) : 2735 - 2745
  • [9] Successful Kidney Transplantation Ameliorates Arterial Stiffness in End-Stage Renal Disease Patients
    Hotta, K.
    Harada, H.
    Sasaki, H.
    Iwami, D.
    Fukuzawa, N.
    Morita, K.
    Seki, T.
    Togashi, M.
    Nonomura, K.
    TRANSPLANTATION PROCEEDINGS, 2012, 44 (03) : 684 - 686
  • [10] Sociodemographic and Geographic Predictors of Quality of Care in United States Patients With End-Stage Renal Disease Due to Lupus Nephritis
    Plantinga, Laura C.
    Drenkard, Cristina
    Patzer, Rachel E.
    Klein, Mitchel
    Kramer, Michael R.
    Pastan, Stephen
    Lim, S. Sam
    McClellan, William M.
    ARTHRITIS & RHEUMATOLOGY, 2015, 67 (03) : 761 - 772